Setsuko buys NFG 75.17: Pfizer : Submits New Drug Application for Palbociclib ; BioBlast Receives Notice Of Allowance From USPTO For Ataxia
{nfg} Pfizer Inc. (PFE:NYSE) announced it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for palbociclib. This NDA requests FDA approval of palbociclib, in combination with letrozole ... ...
38 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home